---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-105182"
form_type: "8-K"
ticker: "KALV"
cik: "0001348911"
company_name: "KalVista Pharmaceuticals, Inc."
filed_at: "2024-09-10T23:59:59+00:00"
generated_at: "2026-05-31T05:36:17.668069+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# KalVista appoints Brian Piekos as CFO effective Sept 9; 100K stock option inducement granted

## Summary
- Brian Piekos joins as CFO; previously CFO of Elicio Therapeutics and Gemini Therapeutics.
- Piekos receives $460K base salary, 40% bonus target, and 100K stock options at $11.87 with 4-year vest.
- Employment agreements for CEO Ben Palleiko and CMO Paul Audhya amended (severance, Section 280G updates).
- KalVista highlights Piekos' experience as it prepares for sebetralstat commercialization.

## SEC filing metadata
- accession: 0000950170-24-105182
- form_type: 8-K
- ticker: KALV
- cik: 0001348911
- company_name: KalVista Pharmaceuticals, Inc.
- filed_at: 2024-09-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348911/000095017024105182/0000950170-24-105182-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348911/000095017024105182/kalv-20240906.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-105182
- JSON: https://secwatch.observer/filing/0000950170-24-105182.json
- Plain text: https://secwatch.observer/filing/0000950170-24-105182.txt

## Key facts
- Executive change
  Brian Piekos was appointed as Chief Financial Officer at KalVista Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Effective September 9, 2024, the Board of Directors (the “Board”) of KalVista Pharmaceuticals, Inc. (the “Company”) appointed Brian Piekos as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1348911/000095017024105182/0000950170-24-105182-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.